Why Arm Is a Strong Buy Despite the 35% Pullback From Peak Levels

Arm Holdings (NASDAQ:ARM | ARM Price Prediction) has been one of 2026’s most dramatic stories, ripping from a January low near $105 to a record $452.70 in June before giving back gains.

With shares now near $315, the question is whether the AI CPU thesis still has room to run or if the easy money has already been made. Our proprietary model says there is more upside, but not the kind investors have gotten used to.

Our 24/7 Wall St. Price Target for Arm

The Arm Holdings story is fundamentally about becoming the default CPU architecture of the agentic AI data center. Our 24/7 Wall St. price target for Arm is $344.98, implying 9.42% upside from the current price of $315.28. Our recommendation is buy with a confidence level of 90%.

A Wild Ride From $105 to $452 and Back

Arm is up 188.43% year to date and 103.89% over the past year, yet the last month has been brutal. Shares are down 21.71% over the past 30 days and 9.33% in the past week, currently sitting 35% below the 52-week high of $452.70. A 10.1% drop on June 23 during a broader semiconductor rout, combined with a New Street Research downgrade to Neutral and executive insider selling, triggered the pullback.

The fundamentals remain strong. Q4 FY2026 revenue hit $1.49 billion, up 20.1% YoY, with non-GAAP EPS of $0.60 beating consensus. Full-year FY2026 revenue reached $4.92 billion (+22.79%), marking a third consecutive year of 20%+ growth. Next earnings land July 29, 2026.

The Case for $448 and Higher

Our bull case final price sits at $448.25, a 42.17% return. The catalyst is Arm AGI CPU, the company’s first data center production silicon. Management flagged more than $2 billion in customer demand across FY2027-FY2028 and a $100+ billion data center CPU TAM by 2030.

Meta is lead partner, and Google, NVIDIA, Microsoft, Oracle, and OpenAI are all building Arm-based silicon. Wall Street bulls have raised targets: TD Cowen to $475, UBS to $470, and Mizuho to $500, targeting $15 billion in agentic AI CPU revenue by fiscal 2031.

What Could Go Wrong

The bear case lands at $268.49, a 14.84% loss. Valuation is the elephant in the room. Arm trades at a trailing P/E of 402 and a forward P/E of 154. Non-GAAP operating margin compressed from 52.8% to 49.1% as R&D surged 43% YoY to $1.911 billion.

Bulls argue this is deliberate investment to capture the agentic AI opportunity, and the FY2026 free cash flow jump of 395.5% supports that framing. Other risks include the Qualcomm/Nuvia trial in Q4 CY2026, 25% U.S. semiconductor tariffs, and an FTC antitrust investigation reported in May.

The Setup: Constructive Above $300, More Compelling Below

Our 24/7 Wall St. price target for Arm is $344.98, a buy at 90% confidence. The bull thesis strengthens if the July 29 earnings report validates the $1.26 billion Q1 FY2027 revenue guide and hyperscaler CPU share holds near 50%.

The thesis weakens if margins compress further without a clear royalty inflection or if the Qualcomm ruling goes against Arm. At this price, the risk/reward tilts positive.

Here is where our model projects Arm could trade in the coming years, assuming Armv9 royalty rates expand and AGI CPU adoption tracks management’s roadmap.

These projections assume Arm continues executing on its AGI CPU roadmap and hyperscaler design wins. Significant upside could result from Meta’s personal superintelligence rollout scaling to its 3B+ user base, while downside risk centers on litigation outcomes and China export policy.

Contact [email protected] for any questions or corrections.